Zobrazeno 1 - 10
of 255
pro vyhledávání: '"Karim, Chamie"'
Autor:
Neal Patel, Alexander Hakansson, Shinji Ohtake, Peter Muraki, James A. Proudfout, Yang Liu, Lisa Webber, Arkaitz Ibarra, Vinnie Y. T. Liu, Elai Davicioni, Karim Chamie, Allan Pantuck, Brian Shuch
Publikováno v:
Cancer Medicine, Vol 12, Iss 5, Pp 6437-6444 (2023)
Abstract Background Risk stratification of kidney cancer patients after nephrectomy may tailor surveillance intensity and selection for adjuvant therapy. Transcriptomic approaches are effective in predicting recurrence, but whether they add value to
Externí odkaz:
https://doaj.org/article/bd78f3f34c2c414f9cd6de33e881a5f4
Autor:
Nathaniel Christian-Miller, Andrew T Lenis, Katherine E Fero, Josef Madrigral, Sriram V Eleswarapu, Karim Chamie, Peyman Benharash
Publikováno v:
Asian Journal of Andrology, Vol 23, Iss 3, Pp 236-239 (2021)
Penile fracture (PF) is a surgical emergency. Given its rarity, we queried a national cohort over an 11-year period to study the temporal and demographic variations in presentation, evaluation, and management of patients with PF compared with a cohor
Externí odkaz:
https://doaj.org/article/ba48db61d92c472981801d32142f5ab1
Autor:
Vishnukamal Golla, Yong Shan, Hemalkumar B. Mehta, Zachary Klaassen, Douglas S. Tyler, Jacques Baillargeon, Ashish M. Kamat, Stephen J. Freedland, John L. Gore, Karim Chamie, Yong-Fang Kuo, Stephen B. Williams
Publikováno v:
European Urology Open Science, Vol 19, Iss , Pp 27-36 (2020)
Background: One out of five patients with muscle-invasive bladder cancer undergo radical cystectomy—a guideline-recommended treatment. Previous studies have primarily evaluated patient characteristics associated with the use of radical cystectomy,
Externí odkaz:
https://doaj.org/article/d67addc8da794827a32d5aad19653954
Publikováno v:
Bladder Cancer. :1-15
Systemic agents including immune checkpoint inhibitors, antibody-drug conjugates, and targeted therapies play a critical role in the management of bladder cancer. Novel localized delivery mechanisms for existing systemic agents explore solutions to i
Publikováno v:
Urology. 174:150-158
Autor:
Peter Muraki, Cory Lee, Neal Patel, Aileen Arevalo, Shinji Ohtake, Neil Mendhiratta, Karim Chamie, Vatche Agopian, Peyman Benharash, Brian Shuch
Publikováno v:
Urology. 173:127-133
To improve the management of cirrhotic patients diagnosed with new renal masses, we used a nationally representative cohort to assess the perioperative outcomes of nephrectomy in the setting of liver disease. The incidences of liver disease and renal
Autor:
Vidit Sharma, Karim Chamie, Mark Schoenberg, Valerie S. Lee, Katherine Fero, Patrick Lec, Julie R. Munneke, David S. Aaronson, Lawrence H. Kushi, Charles P. Quesenberry, Li Tang, Marilyn L. Kwan
Publikováno v:
Urology. 173:134-141
To describe the risk of multiple recurrences in intermediate-risk non-muscle invasive bladder cancer (IR-NMIBC) and their impact on progression. Prognostic studies of IR-NMIBC have focused on initial recurrences, yet little is known about subsequent
Publikováno v:
BMC Urology, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Intravesical Mitomycin-C (MMC) following transurethral resection of bladder tumor (TURBT), while efficacious, is associated with side effects and poor utilization. Continuous saline bladder irrigation (CSBI) has been examined as a
Externí odkaz:
https://doaj.org/article/227a045a1d7e4f1a8646a0ac743a226b
Autor:
Neal Patel, Alexander Hakansson, Shinji Ohtake, Peter Muraki, James A. Proudfout, Yang Liu, Lisa Webber, Arkaitz Ibarra, Vinnie Y. T. Liu, Elai Davicioni, Karim Chamie, Allan Pantuck, Brian Shuch
Publikováno v:
Cancer Medicine. 12:6437-6444
Risk stratification of kidney cancer patients after nephrectomy may tailor surveillance intensity and selection for adjuvant therapy. Transcriptomic approaches are effective in predicting recurrence, but whether they add value to clinicopathologic mo
Autor:
Paul T. Henderson, Chong-xian Pan, Ralph de Vere White, Karim Chamie, Alexandra Drakaki, Clifford G. Tepper, George D. Cimino, Kenneth W. Turteltaub, Susan Airhart, Hongyuan Yang, Ted Ognibene, Kurt Haack, Michael Malfatti, Tzu-yin Lin, Hongyong Zhang, Si-Si Wang, Maike Zimmermann
We report progress on predicting tumor response to platinum-based chemotherapy with a novel mass spectrometry approach. Fourteen bladder cancer patients were administered one diagnostic microdose each of [14C]carboplatin (1% of the therapeutic dose).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ecee25af3630876e71d2c645bb27963
https://doi.org/10.1158/1535-7163.c.6537576
https://doi.org/10.1158/1535-7163.c.6537576